NO963418L - Cyklisk heptapeptid anti-inflammatorisk middel - Google Patents
Cyklisk heptapeptid anti-inflammatorisk middelInfo
- Publication number
- NO963418L NO963418L NO963418A NO963418A NO963418L NO 963418 L NO963418 L NO 963418L NO 963418 A NO963418 A NO 963418A NO 963418 A NO963418 A NO 963418A NO 963418 L NO963418 L NO 963418L
- Authority
- NO
- Norway
- Prior art keywords
- cyclomarin
- inflammatory agent
- cyclic heptapeptide
- isolated
- bacterium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/198,859 US5444043A (en) | 1994-02-18 | 1994-02-18 | Cyclic heptapeptide anti-inflammatory agent |
PCT/US1995/001970 WO1995022339A1 (en) | 1994-02-18 | 1995-02-16 | Cyclic heptapeptide anti-inflammatory agent |
Publications (1)
Publication Number | Publication Date |
---|---|
NO963418L true NO963418L (no) | 1996-08-15 |
Family
ID=22735156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO963418A NO963418L (no) | 1994-02-18 | 1996-08-15 | Cyklisk heptapeptid anti-inflammatorisk middel |
Country Status (15)
Country | Link |
---|---|
US (2) | US5444043A (no) |
EP (1) | EP0744955B1 (no) |
JP (1) | JPH09509318A (no) |
KR (1) | KR100349485B1 (no) |
AT (1) | ATE221385T1 (no) |
AU (1) | AU696517B2 (no) |
BR (1) | BR9506866A (no) |
CA (1) | CA2181827A1 (no) |
CZ (1) | CZ231896A3 (no) |
DE (1) | DE69527610D1 (no) |
FI (1) | FI963194A (no) |
HU (1) | HU221122B1 (no) |
NO (1) | NO963418L (no) |
NZ (1) | NZ281823A (no) |
WO (1) | WO1995022339A1 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5444043A (en) * | 1994-02-18 | 1995-08-22 | The Regents Of The University Of California | Cyclic heptapeptide anti-inflammatory agent |
US5759995A (en) * | 1996-09-05 | 1998-06-02 | Phytera, Inc. | Antiviral treatment |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
WO2006119174A1 (en) * | 2005-04-30 | 2006-11-09 | Ocular Surface Center, P.A. | Method for treating ocular demodex |
KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료 |
US8128968B2 (en) | 2007-08-29 | 2012-03-06 | Tissuetech, Inc. | Compositions and methods for treating Demodex infestations |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
WO2018128826A1 (en) * | 2017-01-06 | 2018-07-12 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of bacterial infections |
WO2019126353A2 (en) * | 2017-12-20 | 2019-06-27 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of bacterial infections |
CN111647050B (zh) * | 2020-05-13 | 2021-11-09 | 中国科学院南海海洋研究所 | 一种怡莱霉素f衍生物及其在制备抗结核分枝杆菌药物中的应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32455E (en) * | 1978-10-16 | 1987-07-07 | Eli Lilly And Company | A-21978 antibiotics and process for their production |
US4331594A (en) * | 1978-10-16 | 1982-05-25 | Eli Lilly And Company | A-21978 Antibiotics and process for their production |
CA1172980A (en) * | 1979-04-02 | 1984-08-21 | Kenji Takemoto | Pentadecapeptide and process for the preparation thereof |
US4950649A (en) * | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
US4342829A (en) * | 1981-05-06 | 1982-08-03 | Eli Lilly And Company | Process for preparing narasin |
US4384043A (en) * | 1981-09-02 | 1983-05-17 | American Cyanamid Company | Process for producing the antibiotic nosiheptide |
US4409210A (en) * | 1982-01-15 | 1983-10-11 | Bristol-Myers Company | Antibiotic compound |
US4677071A (en) * | 1982-03-25 | 1987-06-30 | American Cyanamid Company | Antibiotic agents from S. coeruleorubidus, rubidus |
US4608343A (en) * | 1983-06-23 | 1986-08-26 | American Cyanamid Company | Biologically pure culture of Streptomyces majorciensis Labeda |
US4582639A (en) * | 1984-06-18 | 1986-04-15 | Bristol-Myers Company | Antitumor antibiotic compound |
US4885243A (en) * | 1984-10-09 | 1989-12-05 | Eli Lilly And Company | Process for producing A-21978C derivatives |
US5006466A (en) * | 1986-11-21 | 1991-04-09 | Merck & Co., Inc. | Fermentation analogs of virginiamycin M1 |
US5229362A (en) * | 1986-12-15 | 1993-07-20 | Eli Lilly And Company | Antibiotic A10255 complex and factors, and process and production therefor |
US5217952A (en) * | 1988-02-02 | 1993-06-08 | Fujisawa Pharmaceutical Co., Ltd. | Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof |
US5028590A (en) * | 1988-04-11 | 1991-07-02 | Eli Lilly And Company | Derivatives of A54145 cyclic peptides |
US4977083A (en) * | 1988-04-11 | 1990-12-11 | Eli Lilly And Company | Processes for preparing A54145 compounds |
US5138036A (en) * | 1989-11-13 | 1992-08-11 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14 |
US5336757A (en) * | 1992-02-07 | 1994-08-09 | Harbor Branch Oceanographic Institution, Inc. | Antibacterial peptide and methods of use |
US5444043A (en) * | 1994-02-18 | 1995-08-22 | The Regents Of The University Of California | Cyclic heptapeptide anti-inflammatory agent |
-
1994
- 1994-02-18 US US08/198,859 patent/US5444043A/en not_active Expired - Fee Related
-
1995
- 1995-02-16 CA CA002181827A patent/CA2181827A1/en not_active Abandoned
- 1995-02-16 HU HU9602252A patent/HU221122B1/hu not_active IP Right Cessation
- 1995-02-16 DE DE69527610T patent/DE69527610D1/de not_active Expired - Lifetime
- 1995-02-16 AT AT95911020T patent/ATE221385T1/de not_active IP Right Cessation
- 1995-02-16 AU AU18773/95A patent/AU696517B2/en not_active Ceased
- 1995-02-16 BR BR9506866A patent/BR9506866A/pt not_active Application Discontinuation
- 1995-02-16 NZ NZ281823A patent/NZ281823A/en unknown
- 1995-02-16 JP JP7521914A patent/JPH09509318A/ja active Pending
- 1995-02-16 KR KR1019960704380A patent/KR100349485B1/ko not_active IP Right Cessation
- 1995-02-16 EP EP95911020A patent/EP0744955B1/en not_active Expired - Lifetime
- 1995-02-16 WO PCT/US1995/001970 patent/WO1995022339A1/en active IP Right Grant
- 1995-02-16 CZ CZ962318A patent/CZ231896A3/cs unknown
- 1995-05-23 US US08/447,627 patent/US5593960A/en not_active Expired - Fee Related
-
1996
- 1996-08-15 FI FI963194A patent/FI963194A/fi unknown
- 1996-08-15 NO NO963418A patent/NO963418L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0744955A4 (en) | 1998-12-16 |
CZ231896A3 (en) | 1997-01-15 |
ATE221385T1 (de) | 2002-08-15 |
EP0744955B1 (en) | 2002-07-31 |
DE69527610D1 (de) | 2002-09-05 |
FI963194A (fi) | 1996-09-23 |
WO1995022339A1 (en) | 1995-08-24 |
JPH09509318A (ja) | 1997-09-22 |
KR100349485B1 (ko) | 2002-11-18 |
HU9602252D0 (en) | 1996-10-28 |
AU1877395A (en) | 1995-09-04 |
US5593960A (en) | 1997-01-14 |
AU696517B2 (en) | 1998-09-10 |
US5444043A (en) | 1995-08-22 |
NZ281823A (en) | 1997-11-24 |
HU221122B1 (en) | 2002-08-28 |
HUT75832A (en) | 1997-05-28 |
FI963194A0 (fi) | 1996-08-15 |
EP0744955A1 (en) | 1996-12-04 |
CA2181827A1 (en) | 1995-08-24 |
BR9506866A (pt) | 1997-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO963418L (no) | Cyklisk heptapeptid anti-inflammatorisk middel | |
ZA997767B (en) | Method for producing L-amino acid. | |
TR199701544T1 (xx) | Yeni dolastatin t�revleri,bunlar�n haz�rlanmas� ve kullan�lmas�. | |
FI991477A (fi) | Menetelmä tolterodiinin valmistamiseksi | |
MX9702724A (es) | Lipasa, microorganismo que la produce, procedimiento para la preparacion de dicha lipasa y su uso. | |
AU1444697A (en) | Sialyl-lewisa and sialyl-lewisx epitope analogues | |
AU5485698A (en) | Oxyiminopregnancarbolactone | |
ATE168722T1 (de) | Fo-1289 verbindung und ihre herstellung. | |
CA2187250A1 (en) | Method for Producing a Soluble Protein with Bacteria | |
FI824214L (fi) | Mikro-organismer av slaektet pseudomonas och foerfarande foer nedbrytning av metylgrupphaltiga foereningar i vattenhaltiga loesningar | |
DE69632407D1 (de) | Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung | |
KR870011153A (ko) | 면역억제물질 시클로뎁시펩티드와 그의 제조방법 | |
KR950700988A (ko) | 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof) | |
JPS57159487A (en) | Preparation or bilirubin oxidase | |
ES2139341T3 (es) | Isocomarinas antitumorales. | |
NO996401L (no) | Fremgangsmõte for fremstilling av amider | |
ES480904A1 (es) | Un procedimiento para la produccion del antibiotico mycopla-necin. | |
NO920849L (no) | Fremgangsmaate for fremstilling av l-lysin ved fermentasjon | |
ATE131531T1 (de) | Typ ii-restriktionsendonuklease ssp4800i | |
JPS533593A (en) | Preparation of gel-forming microbial protein | |
KR930703456A (ko) | 발효법에 의한 l-알라닌의 제조방법 | |
IT1276454B1 (it) | Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico. | |
KR920004284A (ko) | 폐수 처리용 미생물 영양 조성물의 제조방법 | |
KR930013091A (ko) | 반코마이신을 생산하는 미생물 | |
JPS5699795A (en) | Preparation of polysaccharide |